ILLUMINA VENTURES

“Sherlock has created a handheld, molecular testing device that is super accurate, inexpensive to produce and works at room temperature,” said Wouter Meuleman, Partner at Illumina Ventures. “They’ve shown us how CRISPR can be harnessed to decentralize and democratize diagnostics.”